Krystal Biotech Future Growth
Future criteria checks 5/6
Krystal Biotech is forecast to grow earnings and revenue by 41.2% and 32.4% per annum respectively. EPS is expected to grow by 40.1% per annum. Return on equity is forecast to be 19.2% in 3 years.
Key information
41.2%
Earnings growth rate
40.1%
EPS growth rate
Biotechs earnings growth | 42.4% |
Revenue growth rate | 32.4% |
Future return on equity | 19.2% |
Analyst coverage | Good |
Last updated | 05 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 655 | 303 | 275 | 241 | 8 |
12/31/2025 | 462 | 184 | 173 | 208 | 10 |
12/31/2024 | 291 | 81 | 95 | 109 | 10 |
9/30/2024 | 242 | 52 | 58 | 63 | N/A |
6/30/2024 | 166 | 106 | -23 | -17 | N/A |
3/31/2024 | 96 | 57 | -54 | -47 | N/A |
12/31/2023 | 51 | 11 | -101 | -89 | N/A |
9/30/2023 | 9 | -30 | -119 | -104 | N/A |
6/30/2023 | N/A | -140 | -130 | -102 | N/A |
3/31/2023 | N/A | -135 | -152 | -111 | N/A |
12/31/2022 | N/A | -140 | -154 | -101 | N/A |
9/30/2022 | N/A | -130 | -188 | -99 | N/A |
6/30/2022 | N/A | -115 | -182 | -87 | N/A |
3/31/2022 | N/A | -104 | -137 | -54 | N/A |
12/31/2021 | N/A | -70 | -116 | -48 | N/A |
9/30/2021 | N/A | -58 | -70 | -35 | N/A |
6/30/2021 | N/A | -52 | -52 | -35 | N/A |
3/31/2021 | N/A | -43 | -45 | -30 | N/A |
12/31/2020 | N/A | -32 | -41 | -26 | N/A |
9/30/2020 | N/A | -27 | -35 | -25 | N/A |
6/30/2020 | N/A | -22 | -29 | -23 | N/A |
3/31/2020 | N/A | -20 | -28 | -22 | N/A |
12/31/2019 | N/A | -19 | -25 | -19 | N/A |
9/30/2019 | N/A | -17 | -21 | -15 | N/A |
6/30/2019 | N/A | -16 | -18 | -13 | N/A |
3/31/2019 | N/A | -13 | -14 | -10 | N/A |
12/31/2018 | N/A | -11 | -12 | -9 | N/A |
9/30/2018 | N/A | -9 | -9 | -8 | N/A |
6/30/2018 | N/A | -11 | N/A | -7 | N/A |
3/31/2018 | N/A | -10 | N/A | -6 | N/A |
12/31/2017 | N/A | -8 | N/A | -4 | N/A |
9/30/2017 | N/A | -7 | N/A | -3 | N/A |
6/30/2017 | N/A | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4KB's forecast earnings growth (41.2% per year) is above the savings rate (1%).
Earnings vs Market: 4KB's earnings (41.2% per year) are forecast to grow faster than the German market (21.1% per year).
High Growth Earnings: 4KB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4KB's revenue (32.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 4KB's revenue (32.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4KB's Return on Equity is forecast to be low in 3 years time (19.2%).